Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm, rectal cancer, rectal disorder, rectal neoplasmRecruitingPhase 22026-06-12NCT07011576

2 results · Page 1 of 1

Swipe the table sideways for more columns.

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alliance Cancer SpecialistsWynnewoodUnited States1
Blue Ridge Cancer Care (Oncology & Hematology Associates of Southwest VA)SalemUnited States1
Illinois Cancer SpecialistsArlington HeightsUnited States21
Maryland Oncology HematologyColumbiaUnited States6
Minnesota Oncology Hematology - PrimaryMaple GroveUnited States1
Missouri Cancer AssociatesColumbiaUnited States17
Northwest Cancer Specialists - CompassPortlandUnited States1
Oncology Associates of Oregon - PrimaryEugeneUnited States1
Rocky Mountain Cancer Center - PrimaryDenverUnited States1
Scri Oncology PartnersNashvilleUnited States156
Texas Oncology - Central/South TexasAustinUnited States6
Texas Oncology - Gulf CoastBeaumontUnited States8
Texas Oncology - Northeast TexasTylerUnited States18
Virginia Oncology AssociatesNorfolkUnited States73